Categories: Artificial IntelligenceBioTechDeliveryDrugLearnMedtechQuantumSimulation
剂泰科技（北京）股份有限公司,METiS TechBio
Investors 1
Mentions in press and media 3
| Date | Title | Description |
| 03.03.2025 | METiS Pharmaceuticals Appoints Mark Herbert as Chief Business Officer | HANGZHOU, China, March 3, 2025 /PRNewswire/ -- METiS Pharmaceuticals, a clinical-stage, AI-driven biotechnology company specializing in innovative drug delivery technologies, today announced the appointment of Mark Herbert as Chief Business... |
| 25.06.2024 | The Dance of Deals: A Look at Recent Investments in Asia's Startup Scene | In the fast-paced world of startup investments, recent deals have been making waves across Asia. From Malaysian platforms securing funding to Japanese companies acquiring new subsidiaries, the dance of deals is in full swing.
Homa2u, a Mala... |
| 24.06.2024 | Deals in brief: Paywatch secures USD 30 million, Ai Palette snags additional funding, Blibli operator acquires home decor startup Dekoruma, and more | NewsDeals in brief: Homa2u secures additional pre-Series A funding from Asia Fund X, Robo Co-op raises USD 700,000 for refugee empowerment initiatives, multiple China deals, and more
Written by KrASIA Writers Homa2u, Robo Co-op, VITG, and m... |
Reviews 0